Prisma Health Cancer Institute Faris — Greenville, South Carolina

Prisma Health Cancer Institute Faris is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Prisma Health Cancer Institute Faris has participated in 252 clinical trials with 168 currently active.

Therapeutic areas: Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greenville

Browse all research sites in South Carolina · View every site in Greenville

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health Cancer Institute Faris?

Prisma Health Cancer Institute Faris has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health Cancer Institute Faris conducted?

Prisma Health Cancer Institute Faris has 252 clinical trials on record, with 168 currently active. Their work covers Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8.

Is Prisma Health Cancer Institute Faris accredited by Crixeo Clinical Trials?

Prisma Health Cancer Institute Faris has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prisma Health Cancer Institute Faris?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.